Hanemann CO - Search Results

1

The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma.

Lyons Rimmer J, Ercolano E, Baiz D, Makhija M, Berger A, Sells T, Stroud S, Hilton D, Adams CL, Hanemann CO. Lyons Rimmer J, et al. Among authors: hanemann co. Cancers (Basel). 2020 Jun 30;12(7):1744. doi: 10.3390/cancers12071744. Cancers (Basel). 2020. PMID: 32629964 Free PMC article.

2

Neurofibromatosis type 1 with involvement of the enteric nerves.

Hanemann CO, Hayward C, Hilton DA. Hanemann CO, et al. J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1163-4. doi: 10.1136/jnnp.2007.120451. J Neurol Neurosurg Psychiatry. 2007. PMID: 17878201 Free PMC article. No abstract available.

3

Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244.

Ammoun S, Ristic N, Matthies C, Hilton DA, Hanemann CO. Ammoun S, et al. Among authors: hanemann co. Neurobiol Dis. 2010 Jan;37(1):141-6. doi: 10.1016/j.nbd.2009.09.017. Epub 2009 Oct 3. Neurobiol Dis. 2010. PMID: 19804833

4

Activation of ERK, AKT and JNK signalling pathways in human schwannomas in situ.

Hilton DA, Ristic N, Hanemann CO. Hilton DA, et al. Among authors: hanemann co. Histopathology. 2009 Dec;55(6):744-9. doi: 10.1111/j.1365-2559.2009.03440.x. Histopathology. 2009. PMID: 19919586

5

Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis.

Zhang H, Hilton DA, Hanemann CO, Zajicek J. Zhang H, et al. Among authors: hanemann co. Brain Pathol. 2011 Sep;21(5):544-57. doi: 10.1111/j.1750-3639.2011.00477.x. Epub 2011 Feb 22. Brain Pathol. 2011. PMID: 21251115 Free PMC article.

6

Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival.

Ammoun S, Schmid MC, Zhou L, Ristic N, Ercolano E, Hilton DA, Perks CM, Hanemann CO. Ammoun S, et al. Among authors: hanemann co. Oncogene. 2012 Mar 29;31(13):1710-22. doi: 10.1038/onc.2011.357. Epub 2011 Sep 5. Oncogene. 2012. PMID: 21892205

7

Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt/β-catenin signaling linked to the PDGFR/Src and Rac/PAK pathways.

Zhou L, Ercolano E, Ammoun S, Schmid MC, Barczyk MA, Hanemann CO. Zhou L, et al. Among authors: hanemann co. Neoplasia. 2011 Dec;13(12):1101-12. doi: 10.1593/neo.111060. Neoplasia. 2011. PMID: 22247700 Free PMC article.

8

The role of insulin-like growth factors signaling in merlin-deficient human schwannomas.

Ammoun S, Schmid MC, Ristic N, Zhou L, Hilton D, Ercolano E, Carroll C, Hanemann CO. Ammoun S, et al. Among authors: hanemann co. Glia. 2012 Nov;60(11):1721-33. doi: 10.1002/glia.22391. Epub 2012 Jul 20. Glia. 2012. PMID: 22821509

9

Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.

Ammoun S, Provenzano L, Zhou L, Barczyk M, Evans K, Hilton DA, Hafizi S, Hanemann CO. Ammoun S, et al. Among authors: hanemann co. Oncogene. 2014 Jan 16;33(3):336-46. doi: 10.1038/onc.2012.587. Epub 2013 Jan 14. Oncogene. 2014. PMID: 23318455

10

Schwannomas and their pathogenesis.

Hilton DA, Hanemann CO. Hilton DA, et al. Among authors: hanemann co. Brain Pathol. 2014 Apr;24(3):205-20. doi: 10.1111/bpa.12125. Epub 2014 Feb 25. Brain Pathol. 2014. PMID: 24450866 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page